Intranasal Oxytocin for Autism Spectrum Disorder and Comorbid Severe Intellectual Disabilities:open-label study
Not Applicable
- Conditions
- Autism spectrum disorder severe intellectual disabilities
- Registration Number
- JPRN-UMIN000024339
- Lead Sponsor
- ational Hospital Organization Hizen Psychiatric Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 7
Inclusion Criteria
Not provided
Exclusion Criteria
CARS-TV less than 30 points self-standing position impossible Weighing less than 20kg History of status epilepticus Possibility of pregnancy Body exhaustion and advanced inspection value or more
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method After 8 weeks administration of intranasal oxytocin The Japanese version of the RBS-R(Repetitive Behavior Scale-Revised)(stereotyped,self-injurious)
- Secondary Outcome Measures
Name Time Method The Japanese version of the RBS-R(Repetitive Behavior Scale-Revised)(compulsive,ritualistic,sameness,restricted interests) The Japanese version of the Aberrant Behavior Checklist(Illitability) The Japanese version of the Sensory Profile Short Version CGI-S CGI-I plasma oxytocin ,salivary oxytocin